zegalogue glucagon

Purchasing Tips: Key Facts About Zegalogue Glucagon

Abstract: Zegalogue (dasiglucagon) is a novel, stable glucagon analog for severe hypoglycemia, offering rapid onset ( 10 min) and room-temperature storage versus traditional lyophilized glucagon. Market trends show rising demand for ready-to-use, room-temperature-stable peptides. Compared to Baqsimi (nasal) and Glucagon (injectable), Zegalogue’s aqueous formulation eliminates reconstitution, improving compliance. Key parameters: 0.6 mg auto-injector, 3-year shelf life. Peptide industry growth (CAGR 8.5%) favors stable analogs. Selection tips: verify FDA/EMA approval, cold-chain logistics (2-8°C for most peptides), and manufacturer GMP certification. Zegalogue’s stability advantage drives its niche in emergency diabetes care.